Title {1} |
Proactive and Integrated Management and Empowerment in Parkinson’s Disease protocol for a randomised controlled trial (PRIME-UK) to evaluate a new model of care |
Trial registration {2} |
Clinicaltrials.gov reference number: submitted awaiting assignment of reference number |
Protocol version {3} |
version 4, 17 August 2022 |
Funding {4} |
Gatsby Foundation |
Author details {5a} |
Fiona E Lithander1,6, Emma Tenison1, Jan Ypinga2, Angelika Halteren2, Matthew Smith1, Katherine Lloyd1, Edward W Richfield3, Danielle E Brazier1, Mícheál Ó Breasail1, Agnes J Smink2, Chris Metcalfe4, William Hollingworth1,4, Bas Bloem2, Marten Munneke2, Yoav Ben-Shlomo1, Sirwan K.L Darweesh2, Emily J Henderson1,5
|
Affiliations |
1Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, BS8 1NU; 2Radboud University Medical Centre; Donders Institute for Brain, Cognition and Behaviour; Department of Neurology; P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands; 3North Bristol NHS Trust, Southmead Hospital, Westbury-on-Trym, Bristol, UK, BS10 5NB; 4Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK, BS8 2PS, 5Royal United Hospitals Bath NHS Foundation Trust, Combe Park, Bath, UK, BA1 3NG, 6 Liggins Institute and Department of Nutrition and Dietetics, University of Auckland. |
Name and contact information for the trial sponsor {5b}
|
University of Bristol Research and Enterprise Development, One Cathedral Square, Bristol, UK, BS1 5DD, research-governance@bristol.ac.uk |
Role of sponsor {5c} |
The sponsor (University of Bristol) and the funding body (Gatsby Foundation) had no involvement in study design, analyses, nor interpretation of the results. |